Thrombotic diseases
Conditions
Interventions
Observation group:None
Control group:None
Sponsors
The Third Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Clinical suspicion of thrombotic disorders: 1. Meet the clinical diagnostic criteria for the diagnosis of acute thrombotic diseases (such as suspected PTE, AMI, IS, etc., see the Guidelines for the Prevention and Treatment of Thrombotic Diseases in China 2018 for specific diagnostic criteria); 2. Within 48 hours of onset, age 18-80 years old; 3. Informed consent and signed written consent. Healthy control group: 1. Match the age and gender of the patient group; 2. No history of cardiovascular and cerebrovascular diseases, no other blood and immune system diseases; 3. No obvious abnormalities were found in the physical examination; 4. Informed consent and signed written consent.
Exclusion criteria
Exclusion criteria: 1. Long-term treatment with antiplatelet drugs (aspirin, clopidogrel, ticagrelor, etc.); 2. Combined with severe infection, sepsis or other serious systemic diseases; 3. Pregnant and lactating females; 4. Those with a history of severe liver and kidney dysfunction or malignant tumors; 5. Those with a history of recent surgery or trauma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet markers;Platelet aggregation function;Platelet count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ejection fraction of the heart;Glasgow Coma Scale Score;Length of hospital stay; | — |
Countries
China
Contacts
Public ContactJie Chen
The Third Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed